Scotiabank Raises its Price Target on Vale (VALE) to $18
On May 27, 2026, Scotiabank analyst Alfonso Salazar raised the firm’s price target on Vale S.A.
Insider Monkey Blog
Nu Holdings (NU) Appoints Rob Livingston as Chief Financial Officer
On June 1, 2026, Nu Holdings Ltd. (NYSE:NU) disclosed in a regulatory filing that Rob Livingston has been appointed CFO, effective July 13.
Here’s Why MINISO (MNSO) is Among the 8 Most Undervalued Growth Stocks to Buy Right Now
On May 29, 2026, JPMorgan analyst Kevin Yin lowered the firm’s price target on MINISO Group Holding Limited (NYSE:MNSO) to $16 from $26 previously and maintained an Overweight...
Scotiabank Raises its Price Target on Sociedad Química y Minera de Chile (SQM)
On May 28, 2026, Scotiabank raised the firm’s price target on Sociedad Química y Minera de Chile S.A.
Goldman Sachs Upgrades Hilton Grand Vacations (HGV) to Neutral
On June 1, 2026, Goldman Sachs analyst Lizzie Dove upgraded Hilton Grand Vacations Inc. (NYSE:HGV) to Neutral from Sell with a price target of $55, up from $44.
Mizuho Maintains Neutral Rating on Comstock Resources (CRK)
On May 27, 2026, Mizuho lowered the firm’s price target on Comstock Resources, Inc. (NYSE:CRK) to $21 from $25 and maintained a Neutral rating on the shares.
Cinemark Holdings (CNK) Reports Highest-Ever Domestic Box Office for May
On June 1, 2026, Cinemark Holdings, Inc. (NYSE:CNK) announced that it delivered its “highest-ever” domestic box office performance for the month of May.
Southwest Airlines (LUV): The Most Undervalued Growth Stock to Buy Right Now
On June 1, 2026, Morgan Stanley raised the firm’s price target on Southwest Airlines Co.
Dell Technologies (DELL): The Best American Stock to Buy and Hold for the Next Decade
On May 31, 2026, Bernstein analyst Mark Newman raised the firm’s price target on Dell Technologies Inc.
Stifel Raises its Price Target on Ciena (CIEN)
On May 29, 2026, Stifel raised the firm’s price target on Ciena Corporation (NYSE:CIEN) to $615 from $585 and maintained a Buy rating on the shares.
Argus Raises its Price Target on Snowflake (SNOW)
On May 29, 2026, Argus raised the firm’s price target on Snowflake Inc. (NYSE:SNOW) to $300 from $250 and maintained a Buy rating on the shares.
Oppenheimer Upgrades Quanta Services (PWR) to Outperform
On May 28, 2026, Oppenheimer upgraded Quanta Services, Inc. (NYSE:PWR) to Outperform from Perform with an $800 price target following a transfer of coverage.
Starbucks (SBUX) Ties Part of Tech Bonuses to AI Usage
On May 28, 2026, Starbucks Corporation (NASDAQ:SBUX) was reported to be tying part of most tech workers’ bonuses to AI usage, according to Bloomberg’s Daniela Sirtori.
Here’s Why Eli Lilly (LLY) is Among the 10 Best American Stocks to Buy and Hold for the Next Decade
On May 31, 2026, Eli Lilly and Company (NYSE:LLY) announced results from the Phase 3 Libretto-432 clinical trial of Retevmo as adjuvant therapy versus placebo in patients with...
BofA Raises its Price Target on Welltower (WELL)
On May 26, 2026, BofA raised the firm’s price target on Welltower Inc. (NYSE:WELL) to $277 from $260 and maintained a Buy rating on the shares.
Raymond James Raises its Price Target on Marvell (MRVL) to $235 from $105
On May 28, 2026, Raymond James raised the firm’s price target on Marvell Technology, Inc. (NASDAQ:MRVL) to $235 from $105 and maintained a Strong Buy rating on the shares.
Jefferies Raises its Price Target on CrowdStrike (CRWD)
On May 29, 2026, Jefferies analyst Joseph Gallo raised the firm’s price target on CrowdStrike Holdings, Inc.
JPMorgan Raises its Price Target on Analog Devices (ADI)
On May 26, 2026, JPMorgan raised the firm’s price target on Analog Devices, Inc. (NASDAQ:ADI) to $450 from $400 and maintained an Overweight rating on the shares.
Hedge Fund and Insider Trading News: Scott Bessent, Ray Dalio, Warren Buffett, Bill Ackman, George Soros, Millennium Management, Citadel Investment Group, Point72 Asset Management, NVIDIA Corp (NVDA), Dell Technologies Inc (DELL), and More
You may be concerned about the recent declines in AI stocks such as NVDA.
Here is Why Pinterest (PINS) is One of the Best Large Cap Stocks Under $30
Back on May 5, Oppenheimer increased its target price for Pinterest Inc. (NYSE:PINS) from $24 to $30, while maintaining an Outperform rating on the stock.
Ongoing Data Center Wave Bodes Well For PG&E Corp. (PCG)
As of the June 3 closing, consensus sentiment around PG&E Corp. (NYSE:PCG) was strongly bullish.
DraftKings (DKNG) to Benefit From Broader Growth Across Prediction Markets
On May 21, following a comprehensive credit card data review of approximately 9 million users, Morgan Stanley updated its stance on the digital gaming sector.
KE Holdings (BEKE) Inspires Confidence With Efficiency-Driven Growth
On May 19, KE Holdings Inc.
Truist Assigns Buy Rating to Genmab (GMAB)
On May 27, coverage of Genmab A/S (NASDAQ:GMAB) was resumed by Truist analyst Gregory Renza.
Northland Initiates Coverage With an Outperform Rating for Aurora Innovation (AUR)
On May 29, Northland assigned an Outperform rating to Aurora Innovation Inc. (NASDAQ:AUR) after initiating coverage of the stock and set a price target of $11.
Coupang (CPNG) is One of the Most Promising Large Cap Stocks Under $30, Here is Why
On May 14, J.Q. Dickinson Salt-Works announced its inaugural international expansion strategy by partnering with Coupang Inc. (NYSE:CPNG).
JBS N.V. (JBS) Still Appears to be an Attractive Large Cap Investment
On May 15, Bank of America Securities reduced the firm’s price target on JBS N.V. (NYSE:JBS) from $21 to $20, resulting in almost 66% revised upside potential.
Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial Data
On May 31, Summit Therapeutics Inc. (NASDAQ:SMMT) presented new clinical data from the international Phase II AK112-206 trial during the American Society of Clinical Oncology.
Jim Cramer’s Opinion on 13 Stocks Like Eli Lilly and Boeing and Increased AI-Related Spending
In this article, we will look at the stocks on which Jim Cramer gave his opinion, as he warned that increased AI-related spending might cause near-term headwind for stocks.
Jim Cramer’s Opinion on 5 Stocks Like Alphabet and NVIDIA and Increased AI-Related Spending
In this article, we will look at Jim Cramer’s Opinion on 5 Stocks Like Alphabet and NVIDIA and Increased AI-Related Spending.
Here is What Makes Hinge Health (HNGE) a Promising Mid-Cap Healthcare Stock
On May 7, Citizens maintained an Outperform rating for Hinge Health Inc. (NYSE:HNGE) while increasing the price target from $65 to $80.
Tango Therapeutics (TNGX) Could Benefit From Pancreatic Ductal Adenocarcinoma Data Announcement
On May 15, the price target on Tango Therapeutics Inc. (NASDAQ:TNGX) was increased from $28 to $55 by Leerink.
Erasca Inc. (ERAS) Inspiring Confidence Through Commercial Collaborations
On May 11, Erasca Inc. (NASDAQ:ERAS) announced a supply agreement and a clinical trial partnership with Merck.
Dyne Therapeutics (DYN) Reaches Key Regulatory Milestone
On May 26, Dyne Therapeutics Inc.
Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy
On May 30, Mineralys Therapeutics Inc.
Praxis Precision Medicines (PRAX) Shares Phase 2/3 POWER1 Study Findings
On June 2, Praxis Precision Medicines Inc. (NASDAQ:PRAX) published the findings of its extensive Phase 2/3 POWER1 study.
Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE)
On May 21, Cantor Fitzgerald analyst Kristen Kluska maintained an Overweight rating on Ultragenyx Pharmaceutical Inc.
What Makes Nektar Therapeutics (NKTR) a Promising Mid-Cap Healthcare Stock
On May 11, Wedbush analyst Martin Fan decreased the price target on Nektar Therapeutics (NASDAQ:NKTR) from $95 to $80 while reiterating a Neutral rating.
Why is Acadia Healthcare Company (ACHC) Highly Favored by Hedge Funds
On May 4, following a strong first-quarter report, Raymond James upgraded its rating on Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from Outperform to Strong Buy.
Dianthus Therapeutics (DNTH) Appears Attractive Amid Solid Product Pipeline
On May 7, Raymond James increased its price target on Dianthus Therapeutics Inc. (NASDAQ:DNTH) from $123 to $125.
Why Are Investors Turning Bullish on Littelfuse (LFUS)?
The Mairs & Power, an investment firm, released the first-quarter 2026 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here.
Hedge Fund Investor Letters Q1 2026
We will be sharing Q1 2026 hedge fund investor letters in this article.
10 Best Large Cap Stocks Under $30 With Highest Upside Potential
In this article, we will take a look at some of the best large cap stocks under $30 that are currently offering attractive upside potential.
5 Best Large Cap Stocks Under $30 With Highest Upside Potential
In this article, we will list the 5 Best Large Cap Stocks Under $30 With Highest Upside Potential.
What Makes Pool Corporation (POOL) a Leader in Pool Distributors?
Argosy Investors, an investment management company, released its Q1 2026 investor letter. A copy is available to download here.
Argosy Investors’ Q1 2026 Investor Letter
Argosy Investors, an investment management company, released its Q1 2026 investor letter.
Jim Cramer Details a Dramatic Trading Session for Salesforce
Salesforce, Inc. (NYSE:CRM) was among Jim Cramer’s stock calls on Mad Money, as he highlighted several opportunities in out-of-favor sectors.
Jim Cramer on Energy Transfer: “I Think It Is Inexpensive and It’s Got a Good Dividend”
Energy Transfer LP (NYSE:ET) was among Jim Cramer’s stock calls on Mad Money, as he highlighted several opportunities in out-of-favor sectors.
Jim Cramer Recommends Elanco Over Zoetis
Zoetis Inc. (NYSE:ZTS) was among Jim Cramer’s stock calls on Mad Money, as he highlighted several opportunities in out-of-favor sectors.
Hedge Fund Resource Center
